002432.SHE Andon Health Co Ltd
- Market cap
- CNY 26.2B
- P/E
- 4.0x
- P/B
- 1.03x
- ROE
- 27.3%
- Dividend yield
- 0.71%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002432.SHE undervalued?
Graham number002432.SHE trades 57.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Andon Health Co Ltd fundamental analysis
No fundamental analysis for Andon Health Co Ltd yet.
Andon Health Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Andon Health Co Ltd
Andon Health Co., Ltd. engages in the research and development, production, and sales of health electronics and smart hardware products in China and internationally. It offers D-Itch stick insect bite healer, pulse oximeter, TENS, massager, bodyfat scale, pregnancy rapid test, blood pressure monitor, thermometer, red light allergy reliever, nasal irrigator, nebulizer, and blood glucose meter. Andon Health Co., Ltd. was founded in 1995 and is based in Tianjin, China.
Full company profileAndon Health Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Andon Health Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 420M | 598M | 564M | 706M | 2.01B | 2.40B | 26.3B | 3.23B | 2.59B | 1.37B | 1.07B |
| Gross Profit | 136M | 180M | 160M | 174M | 1.10B | 1.51B | 20.8B | 1.96B | 1.81B | 872M | 691M |
| Operating Income | 8.22M | -171M | -91.9M | 20.5M | 239M | 1.00B | 18.3B | 1.61B | 2.11B | -297M | -224M |
| EBITDA | -103M | -131M | -77.7M | -141M | 478M | 985M | 18.6B | 829M | 709M | 2.72B | 8.23B |
| Net Income | 14.5M | -166M | 12.7M | 66.4M | 242M | 909M | 16.0B | 1.25B | 1.67B | 2.27B | 6.94B |
| EPS | 0.04 | -0.38 | 0.03 | 0.15 | 0.56 | 2.00 | 34 | 2.77 | 3.78 | 4.88 | 15 |
| Balance Sheet | |||||||||||
| Total Assets | 2.36B | 2.10B | 1.95B | 1.94B | 2.53B | 3.93B | 21.7B | 22.6B | 26.3B | 29.3B | 37.1B |
| Total Liabilities | 815M | 729M | 382M | 342M | 705M | 1.09B | 1.71B | 2.79B | 4.84B | 7.28B | 11.5B |
| Shareholders' Equity | 1.54B | 1.37B | 1.58B | 1.66B | 1.88B | 2.87B | 19.6B | 19.2B | 20.7B | 21.8B | 25.5B |
| Cash & Short-term Investments | 792M | 655M | 528M | 732M | 1.20B | 1.34B | 11.5B | 11.3B | 10.5B | 3.33B | 2.02B |
| Total Debt | 447M | 70.0M | 223M | 198M | 344M | 243M | 290M | 1.51B | 2.63B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -36.5M | -91.9M | -104M | -43.7M | 462M | 293M | 18.2B | 1.77B | 987M | -167M | - |
| Capital Expenditure | 69.6M | 56.5M | 180M | 60.7M | 53.8M | 70.4M | 212M | 213M | 73.9M | 264M | 138M |
| Free Cash Flow | -106M | -148M | -284M | -104M | 408M | 223M | 18.0B | 1.56B | 913M | -431M | -357M |
| Ratios | |||||||||||
| ROE | 0.9% | -12.1% | 0.8% | 4.0% | 12.9% | 31.6% | 82.0% | 6.5% | 8.0% | 10.4% | 27.3% |
| ROA | 0.6% | -7.9% | 0.7% | 3.4% | 9.6% | 23.1% | 73.8% | 5.5% | 6.3% | 7.7% | 18.7% |
| Net Profit Margin | 3.5% | -27.7% | 2.2% | 9.4% | 12.1% | 37.9% | 60.9% | 38.7% | 64.4% | 166.0% | 646.2% |
| Debt to Equity | 0.29x | 0.05x | 0.14x | 0.12x | 0.18x | 0.08x | 0.01x | 0.08x | 0.13x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Andon Health Co Ltd dividends
- Dividend yield
- 0.71%
- Forward dividend
- 1.65 CNY
- Payout ratio
- 8.2%
- Ex-dividend date
- Jun 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 187M | 0.40 | 8.2% |
| 2024 | CNY 191M | 0.43 | 11.4% |
| 2023 | CNY 1.18B | 2.60 | 94.1% |
| 2022 | CNY 319M | 0.68 | 2.0% |
| 2021 | CNY 36.7M | 0.08 | 4.0% |
| 2020 | CNY 6.67M | 0.02 | 2.8% |
| 2019 | CNY 8.68M | 0.02 | 13.1% |
| 2018 | CNY 6.31M | 0.01 | 49.7% |
| 2017 | CNY 11.0M | 0.03 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 15:10 on May 31, 2013.
Who owns Andon Health Co Ltd
- Insiders 30.21%
- Institutions 8.93%
- Public & others 60.86%
- Shares outstanding 466M
- Free float 286M
Andon Health Co Ltd company profile
- Company name
- Andon Health Co Ltd
- Ticker
- 002432.SHE
- ISIN
- CNE100000Q84
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Jun 10, 2010
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,249
- Fiscal year end
- December
- Address
- No. 3 Jinping Street, Tianjin, China, 300190
- Phone
- 86 22 8761 1660
- Website
- jiuan.com
About Andon Health Co Ltd
Andon Health Co., Ltd. engages in the research and development, production, and sales of health electronics and smart hardware products in China and internationally. It offers D-Itch stick insect bite healer, pulse oximeter, TENS, massager, bodyfat scale, pregnancy rapid test, blood pressure monitor, thermometer, red light allergy reliever, nasal irrigator, nebulizer, and blood glucose meter. Andon Health Co., Ltd. was founded in 1995 and is based in Tianjin, China.
Andon Health Co Ltd management
5- Mr. Yi LiuGM & Chairman · born 1967
- Mr. Yong WangDeputy GM & Director · born 1978
- Mr. Ming CongDeputy GM & Employee Director · born 1983
- Mr. Tong WuBoard Secretary · born 1983
- Fei QinHead of Accounting Department